Can a fatty acid lift bipolar depression?
NCT ID NCT06229977
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 2 times
Summary
This study tested whether a natural compound called palmitoylethanolamide (PEA) can help reduce depression in people with bipolar disorder. 34 adults who were already taking a mood stabilizer took PEA or a placebo. Researchers measured changes in depression scores and looked at how the body's own cannabinoids and immune markers responded.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single psychedelic dose rewire the depressed brain?
- Can brain implants read and treat bipolar depression without triggering mania?
- Brain wave patterns and inflammation: a clue to ECT's effectiveness in older adults?
- Could a common antibiotic and supplement lift bipolar depression?
- Could a new pill ease bipolar depression in young people?
- Can a blood test predict who will respond to ketamine for depression?